Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure
- 1 March 1997
- journal article
- editorial
- Published by Elsevier in Kidney International
- Vol. 51 (3), 622-630
- https://doi.org/10.1038/ki.1997.91
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Effect of Serum Parathyroid Hormone and Bone Marrow Fibrosis on the Response to Erythropoietin in UremiaNew England Journal of Medicine, 1993
- A comparison of the responses to recombinant human erythropoietin in normal and uremic subjectsKidney International, 1992
- Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietinAmerican Heart Journal, 1992
- Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneysLife Sciences, 1992
- Improvement in exercise capacity after correction of anemia in patients with end-stage renal failureThe American Journal of Cardiology, 1991
- Treatment of the Anemia of Progressive Renal Failure with Recombinant Human ErythropoietinNew England Journal of Medicine, 1989
- Erythropoiesis and thrombopoiesis in the head-kidney of the sea bass (Dicentrarchus labrax L.): An ultrastructural study.Archives of Histology and Cytology, 1989
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986
- Role of the Kidney in ErythropoiesisNature, 1957